SCHEMBL29904647

SCHEMBL29904647

COc1cc(N2CCC(N3CCN(C)CC3)CC2)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2C(F)(F)F)n1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALK Q9UM73 12/20 0.76
▸ INSR P06213 11/20 0.76
▸ IGF1R P08069 11/20 0.76
▸ EGFR P00533 9/20 0.60
▸ CHEK1 O14757 1/20 0.59
▸ AURKA O14965 1/20 0.59
▸ NUAK1 O60285 1/20 0.59
▸ JAK2 O60674 1/20 0.59
▸ STK10 O94804 1/20 0.59
▸ PRKD3 O94806 1/20 0.59
▸ SLC34A2 O95436 1/20 0.59
▸ CHEK2 O96017 1/20 0.59
▸ ABL1 P00519 1/20 0.59
▸ CD74 P04233 1/20 0.59
▸ ERBB2 P04626 1/20 0.59
▸ LCK P06239 1/20 0.59
▸ FYN P06241 1/20 0.59
▸ FES P07332 1/20 0.59
▸ CSF1R P07333 1/20 0.59
▸ YES1 P07947 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29904673 0.89 INSR (0.84) ALKINSRIGF1REGFRCHEK1
SCHEMBL27360981 0.87 ALK (0.77) ALKINSRIGF1REGFRCHEK1
SCHEMBL26906852 0.86 ALK (0.77) ALKINSRIGF1REGFRCHEK1
SCHEMBL11916553 0.86 ALK (1.00) ALKINSRIGF1REGFRCHEK1
SCHEMBL29084070 0.86 EGFR (0.64) ALKINSRIGF1REGFRCHEK1
SCHEMBL26906516 0.86 EGFR (0.80) ALKINSRIGF1REGFRMET
SCHEMBL29904619 0.86 ALK (0.74) ALKINSRIGF1REGFRCHEK1
SCHEMBL24179137 0.85 ALK (0.73) ALKINSRIGF1REGFRCHEK1
SCHEMBL26906856 0.85 ALK (0.73) ALKINSRIGF1REGFRCHEK1
SCHEMBL26906628 0.85 ALK (0.75) ALKINSRIGF1REGFRCHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240228458-A1 PYRIMIDINE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND THERAPEUTIC PHARMACEUTICAL COMPOSITION COMPRISING SAME THERAPEX CO., LTD. (KR) 2024-07-11 — — US claimed
EP-4286376-A1 PYRIMIDINE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND THERAPEUTIC PHARMACEUTICAL COMPOSITION COMPRISING SAME Therapex Co., Ltd. (KR) 2023-12-06 — — EP claimed
WO-2022211573-A1 PYRIMIDINE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND THERAPEUTIC PHARMACEUTICAL COMPOSITION COMPRISING SAME 주식회사 테라펙스 2022-10-06 — — WO claimed
US-20240228458-A1 PYRIMIDINE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND THERAPEUTIC PHARMACEUTICAL COMPOSITION COMPRISING SAME THERAPEX CO., LTD. (KR) 2024-07-11 — — US disclosed
EP-4286376-A1 PYRIMIDINE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND THERAPEUTIC PHARMACEUTICAL COMPOSITION COMPRISING SAME Therapex Co., Ltd. (KR) 2023-12-06 — — EP disclosed
WO-2022211573-A1 PYRIMIDINE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND THERAPEUTIC PHARMACEUTICAL COMPOSITION COMPRISING SAME 주식회사 테라펙스 2022-10-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240228458-A1 PYRIMIDINE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND THERAPEUTIC PHARMACEUTICAL COMPOSITION COMPRISING SAME EGFR, ERBB2, ERBB3 ALK 120/4885INSR 607/4885IGF1R 592/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback